Skip to main content
Log in

Die extrapulmonalen Auswirkungen der Lungenüberblähung bei COPD

Extrapulmonary consequences of lung hyperinflation in COPD

  • Leitthema
  • Published:
Der Pneumologe Aims and scope

Zusammenfassung

Die extrapulmonalen Auswirkungen der Lungenüberblähung betreffen Herzfunktion und Muskulatur von Patienten mit COPD. So ist ein Zusammenhang zwischen der Überblähung der Lunge bei COPD und der verminderten Füllung des Herzens in verschiedenen Untersuchungen gezeigt worden. Die verminderte kardiale Füllung führt wiederum zu einem verminderten Schlagvolumen und verstärkt möglicherweise die Belastungsintoleranz bei COPD. Interventionelle Maßnahmen zur Reduktion der Lungenüberblähung bewirken eine verbesserte kardiale Funktion. Durch die belastungsintoleranzinduzierte Dekonditionierung ist indirekt auch die Skelettmuskulatur von der Lungenüberblähung betroffen.

Abstract

Cardiac dysfunction and skeletal muscle dysfunction are extrapulmonary consequences of lung hyperinflation in chronic obstructive pulmonary disease (COPD). Several studies demonstrated that lung hyperinflation is related to an underfilling of the heart, which in turn leads to a reduced cardiac output and is associated with a further worsening of exercise intolerance in COPD. Interventional studies showed that cardiac function can be improved by interventional measures for reduction of lung hyperinflation. Skeletal muscle deconditioning due to exercise intolerance is an indirect consequence of lung hyperinflation in COPD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Wigh RE (1978) On defining microcardia: application in pulmonary emphysema. South Med J 71(2):150–154

    Article  CAS  PubMed  Google Scholar 

  2. Thurlbeck WM, Simon G (1978) Radiographic appearance of the chest in emphysema. AJR Am J Roentgenol 130(3):429–440

    Article  CAS  PubMed  Google Scholar 

  3. Hutsebaut J, Scano G, Garcia-Herreros P, Degre S, De Coster A, Sergysels R (1981) Hemodynamic characteristics in chronic obstructive lung disease as related to cardiac size. Respiration 41(1):25–32

    Article  CAS  PubMed  Google Scholar 

  4. Butler J, Schrijen F, Henriquez A, Polu JM, Albert RK (1988) Cause of the raised wedge pressure on exercise in chronic obstructive pulmonary disease. Am Rev Respir Dis 138(2):350–354

    Article  CAS  PubMed  Google Scholar 

  5. Albert RK, Muramoto A, Caldwell J, Koepsell T, Butler J (1985) Increases in intrathoracic pressure do not explain the rise in left ventricular end-diastolic pressure that occurs during exercise in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 132(3):623–627

    CAS  PubMed  Google Scholar 

  6. Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE (2002) Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 166(3):314–322

    Article  PubMed  Google Scholar 

  7. Criner GJ, Scharf SM, Falk JA, Gaughan JP, Sternberg AL, Patel NB et al (2007) Effect of lung volume reduction surgery on resting pulmonary hemodynamics in severe emphysema. Am J Respir Crit Care Med 176(3):253–260

    Article  PubMed  PubMed Central  Google Scholar 

  8. Vassaux C, Torre-Bouscoulet L, Zeineldine S, Cortopassi F, Paz-Diaz H, Celli BR et al (2008) Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J 32(5):1275–1282

    Article  CAS  PubMed  Google Scholar 

  9. Lammi MR, Ciccolella D, Marchetti N, Kohler M, Criner GJ (2012) Increased oxygen pulse after lung volume reduction surgery is associated with reduced dynamic hyperinflation. Eur Respir J 40(4):837–843

    Article  PubMed  Google Scholar 

  10. Travers J, Laveneziana P, Webb KA, Kesten S, O’Donnell DE (2007) Effect of tiotropium bromide on the cardiovascular response to exercise in COPD. Respir Med 101(9):2017–2024

    Article  CAS  PubMed  Google Scholar 

  11. Boussuges A, Pinet C, Molenat F, Burnet H, Ambrosi P, Badier M et al (2000) Left atrial and ventricular filling in chronic obstructive pulmonary disease. An echocardiographic and Doppler study. Am J Respir Crit Care Med 162(2 Pt 1):670–675

    Article  CAS  PubMed  Google Scholar 

  12. Watz H, Waschki B, Meyer T, Kretschmar G, Kirsten A, Claussen M et al (2010) Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest 138(1):32–38

    Article  PubMed  Google Scholar 

  13. Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H (2008) Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 177(7):743–751

    Article  PubMed  Google Scholar 

  14. Watz H, Waschki B, Kirsten AM, Claussen M, Magnussen H (2008) Heart failure in chronic obstructive pulmonary disease (COPD). Dtsch Med Wochenschr 133(14):717–719

    Article  CAS  PubMed  Google Scholar 

  15. Watz H, Arzt M (2014) COPD and heart disease. Herz 39(1):53–57

    Article  CAS  PubMed  Google Scholar 

  16. Jorgensen K, Houltz E, Westfelt U, Nilsson F, Schersten H, Ricksten SE (2003) Effects of lung volume reduction surgery on left ventricular diastolic filling and dimensions in patients with severe emphysema. Chest 124(5):1863–1870

    Article  PubMed  Google Scholar 

  17. Cuttica MJ, Colangelo LA, Shah SJ, Lima J, Kishi S, Arynchyn A et al (2015) Loss of lung health from young adulthood and cardiac phenotypes in middle age. Am J Respir Crit Care Med 192(1):76–85

    Article  PubMed  PubMed Central  Google Scholar 

  18. Watz H (2015) The lungs and the heart. Am J Respir Crit Care Med 192(1):7–8

    Article  PubMed  Google Scholar 

  19. Jorgensen K, Muller MF, Nel J, Upton RN, Houltz E, Ricksten SE (2007) Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI study. Chest 131(4):1050–1057

    Article  PubMed  Google Scholar 

  20. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA et al (2010) Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 362(3):217–227

    Article  PubMed  PubMed Central  Google Scholar 

  21. Grau M, Barr RG, Lima JA, Hoffman EA, Bluemke DA, Carr JJ et al (2013) Percent emphysema and right ventricular structure and function: the multi-ethnic study of atherosclerosis-lung and multi-ethnic study of atherosclerosis-right ventricle studies. Chest 144(1):136–144

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Smith BM, Prince MR, Hoffman EA, Bluemke DA, Liu CY, Rabinowitz D et al (2013) Impaired left ventricular filling in COPD and emphysema: Is it the heart or the lungs?: the multi-ethnic study of atherosclerosis COPD study. Chest 144(4):1143–1151

    Article  PubMed  PubMed Central  Google Scholar 

  23. Rossi A, Aisanov Z, Avdeev S, Di Maria G, Donner CF, Izquierdo JL et al (2015) Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respir Med 109(7):785–802

    Article  PubMed  Google Scholar 

  24. Watz H (2016) Chronic obstructive pulmonary disease: When pulmonologists do something good for the heart. Am J Respir Crit Care Med 193(7):703–704

    Article  PubMed  Google Scholar 

  25. Stone IS, Barnes NC, James WY, Midwinter D, Boubertakh R, Follows R et al (2016) Lung deflation and cardiovascular structure and function in chronic obstructive pulmonary disease. A randomized controlled trial. Am J Respir Crit Care Med 193(7):717–726

    Article  PubMed  Google Scholar 

  26. Waschki B, Kirsten AM, Holz O, Mueller KC, Schaper M, Sack AL et al (2015) Disease progression and changes in physical activity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 192(3):295–306

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Watz.

Ethics declarations

Interessenkonflikt

H. Watz gibt an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von dem Autor durchgeführten Studien an Menschen oder Tieren.

Additional information

Redaktion

H. Worth, Fürth

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Watz, H. Die extrapulmonalen Auswirkungen der Lungenüberblähung bei COPD. Pneumologe 14, 20–23 (2017). https://doi.org/10.1007/s10405-016-0086-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10405-016-0086-6

Schlüsselwörter

Keywords

Navigation